Alphamab Oncology Announces the Results of a Phase III Clinical Study of Anbenitamab (KN026) were Published in Annals of Oncology
SUZHOU, China, Jan. 27, 2026 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) announced that the results from a phase III clinical study for the treatment of HER2-positive gastric or gastroesophageal junction cancer (GC/GEJ) of anbenitamab...
ICP DAS-BMP at WHX Dubai 2026 Spotlights Low-Migration and Low-Friction TPU
HSINCHU, Jan. 27, 2026 /PRNewswire/ -- ICP DAS-BMP (Biomedical Polymers), a Taiwan-based manufacturer and supplier of medical-grade TPU (thermoplastic polyurethane), is pleased to announce its participation in WHX Dubai 2026 (formerly Arab Health),...
New "MedTech Advance" Sourcing Directory Launches to Streamline Global Medical Device Manufacturing
Comprehensive e-book accelerates product development by connecting R&D and procurement teams with global suppliers. TAICHUNG, Jan. 27, 2026 /PRNewswire/ -- Today marks the official release of MedTech Advance, a comprehensive digital buyer's...
REALTY ONE GROUP CELEBRATES 20 YEARS OF COMMUNITY IMPACT, REPORTS STRONG 2025 GIVING RESULTS
LAGUNA NIGUEL, Calif., Jan. 27, 2026 /PRNewswire/ -- Realty ONE Group International, a modern, purpose-driven lifestyle brand and one of the fastest-growing real estate franchisors in the world, today proudly announced its 2025 year-end giving...
Heartbeats Shareholder Mr Lu Min Yong Honoured as "Global Chinese Role Model" at the 2026 Spring Festival Gala Evening
SYDNEY and BEIJING, Jan. 27, 2026 /PRNewswire/ -- Heartbeats proudly congratulates its shareholder, Lu Min Yong, on being awarded the title of "全球华人楷模" (Global Chinese Role Model) at the Global Chinese Spring Festival Gala Evening held as part of...
Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for Relapsed or Refractory Multiple Myeloma
SAN FRANCISCO and SUZHOU, China, Jan. 27, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of...
Reeracoen Study Finds Malaysian Employers Taking a More Targeted Approach to Hiring in 2026
Tighter labor market and rising costs prompt shift toward skills-aligned recruitment KUALA LUMPUR and PENANG, Malaysia, Jan. 27, 2026 /PRNewswire/ -- Reeracoen Malaysia has released its Hiring Trends Year-on-Year Comparison 2024 vs. 2025 , showing...
WireBarley Partners with LAFC in First Deal for Korean Fintech
SEOUL, South Korea, Jan. 27, 2026 /PRNewswire/ -- Global fintech company WireBarley has announced a multi-year strategic partnership with Los Angeles Football Club (LAFC), becoming the club's Official Remittance Partner and the first Korean fintech...